Soon-to-be-introduced oral-antivirals molnupiravir and paxlovid may prove a game-changer in the fight against SARS-CoV-2 and its new variants, such as Omicron, experts feel. The drugs will especially be useful in countries like India where a sizeable population is fully or partly vaccinated or have hybrid immunity — natural infection and recovery followed by vaccination.